• Je něco špatně v tomto záznamu ?

The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions

L. Sommerova, M. Anton, P. Bouchalova, H. Jasickova, V. Rak, E. Jandakova, I. Selingerova, M. Bartosik, B. Vojtesek, R. Hrstka,

. 2019 ; 163 (-) : 185-192. [pub] 20190131

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006612

Cervical cancer is one of the most common malignancies in women. MicroRNAs (miRNAs) are involved in a variety of fundamental cellular processes, including carcinogenesis. The potential utilization of aberrantly expressed miRNAs as novel biomarkers in cervical cancer diagnostics is growing. We investigated miRNA expression profiles during the progression of dysplasia in cervical epithelium to identify aberrantly expressed miRNAs. High-throughput miRNA profiling of high-grade precancerous lesions identified 79 miRNAs showing significant difference in expression values compared to normal cervical epithelium. Ten selected miRNAs were subsequently measured in an independent group of samples to validate them as promising biomarkers of cervical carcinogenesis. MicroRNAs miR-10b-5p, miR-34c-5p, miR-409-3p and miR-411-5p were confirmed as downregulated, while miR-10a-5p, miR-132-3p, miR-141-5p were significantly upregulated in dysplastic cervical tissues. Further investigation revealed an inverse correlation of miR-409-3p with E6 mRNA levels in precancerous cervical lesions. Subsequent in vitro analyses showed a direct involvement of this miRNA in the regulation of E6 oncogene levels, thus confirming a potential tumor suppressor function of miR-409-3p in cervical malignancies. Hence, miR-409-3p may represent a useful early marker and a potential therapeutic target for cervical cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006612
003      
CZ-PrNML
005      
20240229093913.0
007      
ta
008      
200511e20190131ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.antiviral.2019.01.019 $2 doi
035    __
$a (PubMed)30711417
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Sommerova, Lucia $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
245    14
$a The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions / $c L. Sommerova, M. Anton, P. Bouchalova, H. Jasickova, V. Rak, E. Jandakova, I. Selingerova, M. Bartosik, B. Vojtesek, R. Hrstka,
520    9_
$a Cervical cancer is one of the most common malignancies in women. MicroRNAs (miRNAs) are involved in a variety of fundamental cellular processes, including carcinogenesis. The potential utilization of aberrantly expressed miRNAs as novel biomarkers in cervical cancer diagnostics is growing. We investigated miRNA expression profiles during the progression of dysplasia in cervical epithelium to identify aberrantly expressed miRNAs. High-throughput miRNA profiling of high-grade precancerous lesions identified 79 miRNAs showing significant difference in expression values compared to normal cervical epithelium. Ten selected miRNAs were subsequently measured in an independent group of samples to validate them as promising biomarkers of cervical carcinogenesis. MicroRNAs miR-10b-5p, miR-34c-5p, miR-409-3p and miR-411-5p were confirmed as downregulated, while miR-10a-5p, miR-132-3p, miR-141-5p were significantly upregulated in dysplastic cervical tissues. Further investigation revealed an inverse correlation of miR-409-3p with E6 mRNA levels in precancerous cervical lesions. Subsequent in vitro analyses showed a direct involvement of this miRNA in the regulation of E6 oncogene levels, thus confirming a potential tumor suppressor function of miR-409-3p in cervical malignancies. Hence, miR-409-3p may represent a useful early marker and a potential therapeutic target for cervical cancer.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a down regulace $7 D015536
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidský papilomavirus 16 $x genetika $7 D052162
650    _2
$a lidský papilomavirus 18 $x genetika $7 D052161
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x genetika $7 D035683
650    _2
$a onkogenní proteiny virové $x genetika $7 D009856
650    _2
$a represorové proteiny $x genetika $7 D012097
650    _2
$a skvamózní intraepiteliální léze $x genetika $x virologie $7 D000081483
650    _2
$a upregulace $7 D015854
650    _2
$a nádory děložního čípku $x genetika $x virologie $7 D002583
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Anton, Milan $u Department of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty Masaryk University, Obilni trh 11, 602 00 Brno, Czech Republic.
700    1_
$a Bouchalová, Pavla $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. $7 xx0106729
700    1_
$a Jasickova, Hedvika $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
700    1_
$a Rak, Vladimir $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
700    1_
$a Jandakova, Eva $u Department of Pathology, University Hospital Brno and Medical Faculty Masaryk University, Jihlavska 20, 625 00 Brno, Czech Republic.
700    1_
$a Selingerova, Iveta $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
700    1_
$a Bartosik, Martin $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
700    1_
$a Vojtesek, Borivoj $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
700    1_
$a Hrstka, Roman $u RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. Electronic address: hrstka@mou.cz.
773    0_
$w MED00000480 $t Antiviral research $x 1872-9096 $g Roč. 163 (20190131), s. 185-192
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30711417 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20240229093907 $b ABA008
999    __
$a ok $b bmc $g 1525470 $s 1096668
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 163 $c - $d 185-192 $e 20190131 $i 1872-9096 $m Antiviral research $n Antiviral Res $x MED00000480
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...